RecruitingNCT04896684

Chronic Intestinal Pathologies Analytical Cohort at TouLouse


Sponsor

University Hospital, Toulouse

Enrollment

300 participants

Start Date

Apr 29, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

In the general population, the percentage of people with at least one digestive disease is 16.7%. Among these digestive diseases, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and patients who should benefit from digestive examinations as part of a screening oriented either by the patient's family history or following the performance of an immunological screening test ( FIT) in the stool will be studied. The aim of this project is to build a biological collection with associated clinical data for research projects.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria6

  • Patient requiring endoscopic explorations for screening or follow-up in the context of a suspected IBS or IBD or colorectal cancer Or
  • Patient with IBD requiring surgical management
  • Patient over 18 years old
  • Patient able to read and understand the information leaflet
  • Patients who have given their consent to participate in the study
  • Patients affiliated to a social security system (including AME)

Exclusion Criteria5

  • Patients who have received antibiotic treatments in the 10 days preceding endoscopic exploration
  • Pregnant or breastfeeding patients
  • Patients under 18 years old
  • Patients under guardianship or curatorship
  • Patients unable to sign a free and informed consent

Interventions

BIOLOGICALblood and intestinal biopsy sampling

24 mL of blood and 10 intestinal biopsies will be sampled


Locations(1)

Rangueil University Hospital

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04896684


Related Trials